Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interaction.
Aromatic
CD95
Cell migration
Fas
Lupus
Mutagenesis
Peptidomimetic
Phospholipase
Protein protein interaction
Journal
Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377
Informations de publication
Date de publication:
01 11 2019
01 11 2019
Historique:
received:
31
07
2019
revised:
30
08
2019
accepted:
03
09
2019
pubmed:
19
9
2019
medline:
15
9
2020
entrez:
19
9
2019
Statut:
ppublish
Résumé
Proceeding our effort to study protein-protein interaction between the death receptor CD95 and phospholipase PLCγ1, we present in the current work chameleon-like traits of peptidomimetic inhibitors. Minute analysis of the interaction suggests that most of the binding energy relies on van der Waals contacts rather than more specific features, such as hydrogen bonds or salt bridges. The two most important positions of the peptoid for its interaction with PLCγ1 (Arg184 and Arg187) were modified to test this hypothesis. While Arg184 proves to be exchangeable for Trp, with no alteration in affinity, the nature of the amino acid replacing Arg187 is more dependent on its positive charge. However, affinity can be partially recovered by increasing van der Waals interactions. Overall, this study shows that for both positions, a subtle balance exists between hydrophobicity, surface contacts and affinity for CD95/PLCγ1, and provides information for the generation of new therapeutic compounds toward this druggable target.
Identifiants
pubmed: 31526605
pii: S0960-894X(19)30619-5
doi: 10.1016/j.bmcl.2019.126669
pii:
doi:
Substances chimiques
fas Receptor
0
Arginine
94ZLA3W45F
Phospholipase C gamma
EC 3.1.4.3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
126669Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.